Combats free radicals
Phase 2 (Weeks 5 through 8): 0.50mg per week The first therapeutic dose level
Medicinal Uses of L-Lysine: Past and Future
By providing immediate and effective delivery of essential nutrients, it can enhance energy levels, support the immune system, and improve overall health
Simuni, Tanya|Uribe, Liz|Cho, Hyunkeun Ryan|Caspell-Garcia, Chelsea|Coffey, Christopher S|Siderowf, Andrew|Trojanowski, John Q|Shaw, Leslie M|Seibyl, John|Singleton, Andrew|Toga, Arthur W|Galasko, Doug|Foroud, Tatiana|Tosun, Duygu|Poston, Kathleen|Weintraub, Daniel|Mollenhauer, Brit|Tanner, Caroline M|Kieburtz, Karl|Chahine, Lana M|Reimer, Alyssa|Hutten, Samantha J|Bressman, Susan|Marek, Kenneth|Arnedo, Vanessa|Clark, Adrienne|Fraiser, Mark|Kopil, Catherine|Chowdhury, Sohini|Sherer, Todd|Daegele, Nichole|Casaceli, Cynthia|Dorsey, Ray|Wilson, Renee|Mahes, Sugi|Salerno, Christina|Crawford, Karen|Casalin, Paola|Malferrari, Giulia|Weisz, Mali Gani|Orr-Urtreger, Avi|Montine, Thomas|Baglieri, Chris|Christini, Amanda|Russell, David|Dahodwala, Nabila|Giladi, Nir|Factor, Stewart|Hogarth, Penelope|Standaert, David|Hauser, Robert|Jankovic, Joseph|Saint-Hilaire, Marie|Richard, Irene|Shprecher, David|Fernandez, Hubert|Brockmann, Katrina|Rosenthal, Liana|Barone, Paolo|Espay, Alberto|Rowe, Dominic|Marder, Karen|Santiago, Anthony|Hu, Shu-Ching|Isaacson, Stuart|Corvol, Jean-Christophe|Ruiz Martinez, Javiar|Tolosa, Eduardo|Tai, Yen|Politis, Marios|Smejdir, Debra|Rees, Linda|Williams, Karen|Kausar, Farah|Williams, Karen|Richardson, Whitney|Willeke, Diana|Peacock, Shawnees|Sommerfeld, Barbara|Freed, Alison|Wakeman, Katrina|Blair, Courtney|Guthrie, Stephanie|Harrell, Leigh|Hunter, Christine|Thomas, Cathi-Ann|James, Raymond|Zimmerman, Grace|Brown, Victoria|Mule, Jennifer|Hilt, Ella|Ribb, Kori|Ainscough, Susan|Wethington, Misty|Ranola, Madelaine|Mejia Santana, Helen|Moreno, Juliana|Raymond, Deborah|Speketer, Krista|Carvajal, Lisbeth|Carvalo, Stephanie|Croitoru, Ioana|Garrido, Alicia|Payne, Laura Marie|Viswanth, Veena|Severt, Lawrence|Facheris, Maurizio|Soares, Holly|Mintun, Mark A.|Cedarbaum, Jesse|Taylor, Peggy|Biglan, Kevin|Vandenbroucke, Emily|Haider Sheikh, Zulfiqar|Bingol, Baris|Fischer, Tanya|Sardi, Pablo|Forrat, Remi|Reith, Alastair|Egebjerg, Jan|Ahlberg Hillert, Gabrielle|Saba, Barbara|Min, Chris|Umek, Robert|Mather, Joe|De Santi, Susan|Post, Anke|Boess, Frank|Taylor, Kirsten|Grachev, Igor|Avbersek, Andreja|Muglia, Pierandrea|Merchant, Kaplana|Tauscher, Johannes Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study Lancet Neurology [14744422]
